Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Cytokinetics: Q4 Earnings Snapshot
Cytokinetics: Q4 Earnings Snapshot
Associated Press Finance
Wed, February 25, 2026 at 6:17 AM GMT+9 1 min read
In this article:
CYTK
+2.70%
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Tuesday reported a loss of $183 million in its fourth quarter.
The South San Francisco, California-based company said it had a loss of $1.50 per share.
The results did not meet Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.48 per share.
The biopharmaceutical company posted revenue of $17.8 million in the period, which beat Street forecasts. Six analysts surveyed by Zacks expected $3.9 million.
For the year, the company reported a loss of $785 million, or $6.54 per share. Revenue was reported as $88 million.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on CYTK at
Terms and Privacy Policy
Privacy Dashboard
More Info